No Picture
Trading Ideas

Inovio says COVID-19 vaccine produces antibodies in mice, guinea pigs

“We saw antibody responses that do many of the things we would want to see in an eventual vaccine,” said Dr. David Weiner, director of the vaccine and immunotherapy center at the Wistar Institute, which has collaborated with Inovio. Inovio, which began human testing of its vaccine in April, said preliminary results from that trial are expected in June. …read more […]

No Picture
Trading Ideas

The Smartest Way to Protect Your Money

More money. More money. More money.
Everywhere we look, folks are calling for more money. From the head of the Federal Reserve telling Congress to spend as much as it can to business owners begging Trump to keep the free money flowing.
By all measures, it’s working.
It’s no coincidence that stocks soared on Monday… just a day after Congress conjured up another $3 trillion worth of stimulus proposals.
The action we saw on Monday was quite good. Investors with the brains to play this mess are doing incredibly well.
For example, we wrote our Alpha Money Flow subscribers on Monday afternoon and told them …read more […]

No Picture
Trading Ideas

AstraZeneca-Merck Lynparza Prostate Cancer Treatment Gets FDA Approval

AstraZeneca Plc’s (AZN) and Merck Co.’s (MRK) Lynparza drug has received a green light from the U.S. Food and Drug Administration (FDA) for the treatment of patients with advanced prostate cancer.The FDA approval was awarded following results from a Phase III trial, which found that the Lynparza drug treatment reduced the risk of disease progression or death by 66%.Prostate cancer is the second-most common cancer type in men and despite an increase in the number of available therapies for men suffering from the disease, five-year survival remains low.Lynparza is a first-in-class PARP inhibitor, which is a targeted treatment to potentially …read more […]